Sickle Cell Disease Trial, Recruiting (NCT06555939)

Sickle Cell Disease Trial, Recruiting NCT06555939 Sponsor: Boston Children's Hospital Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06555939 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 8 and 25 years old at the start of the study
You have been diagnosed with Sickle Cell Disease (including types HbSS, HbSC, HbS-Beta Thalassemia, or a related blood disorder)
You currently receive your medical care at the Dana-Farber Cancer Institute / Boston Children's Hospital (DFCI/BCH) Blood Disorders Center
You have scored above 9 on a standard questionnaire used to measure depression (PHQ-9) or anxiety (GAD), meaning you are experiencing noticeable symptoms of depression or anxiety
You can speak English or Spanish (required for taking part in the PRISM therapy sessions)
You can read English or Spanish (required for filling out study surveys and questionnaires)
You are considered by the study doctor to be able to take part in the therapy sessions and complete written questionnaires
You are willing and able to attend all required study visits and follow the study's guidelines

Who may not be able to join:

Anyone who does not meet all of the requirements listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617.632.5286

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06555939

Sponsor: Boston Children's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 617.632.5286

More information: https://clinicaltrials.gov/study/NCT06555939

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 8 and 25 years old at the start of the study
You have been diagnosed with Sickle Cell Disease (including types HbSS, HbSC, HbS-Beta Thalassemia, or a related blood disorder)
You currently receive your medical care at the Dana-Farber Cancer Institute / Boston Children's Hospital (DFCI/BCH) Blood Disorders Center
You have scored above 9 on a standard questionnaire used to measure depression (PHQ-9) or anxiety (GAD), meaning you are experiencing noticeable symptoms of depression or anxiety
You can speak English or Spanish (required for taking part in the PRISM therapy sessions)
You can read English or Spanish (required for filling out study surveys and questionnaires)
You are considered by the study doctor to be able to take part in the therapy sessions and complete written questionnaires
You are willing and able to attend all required study visits and follow the study's guidelines

Who may not be able to join:

Anyone who does not meet all of the requirements listed above

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Boston Children's Hospital

Registry

ClinicalTrials.gov

Start date

23 October 2025

Est. completion

1 September 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Enrollment rate (feasibility)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov